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Objectives: Our objectives were to delineate the clinicopathologic character- 
istics of adrenocorticotropin-secreting bronchopulmonary carcinoid tu- 
mors causing Cushing's syndrome and to derive from these findings a 
rational approach to diagnosis and surgical management of this unusual 
condition. Methods: We conducted a retrospective, chart-review analysis of 
seven consecutive patients treated at the Massachusetts General Hospital 
over a 16-year period. Results: The patients uniformly had symptoms of 
marked hypercortisolism, and the underlying lung lesions remained clini- 
cally occult for a mean of 24 months. Standard endocrine testing was 
misleading in 83% of patients, reinforcing the need for an alternative 
diagnostic strategy based on petrosal sinus catheterization and computed 
tomography of the chest. Although 72% of the tumors were typical 
carcinoids by standard criteria, 57% demonstrated microscopic evidence of 
local invasiveness, and 43% were associated with mediastinal ymph node 
metastases. Eighty-six percent of patients have been cured by pulmonary 
resection a mean of 59 months after the operation, but 50% of these 
required a second operation for resection of involved lymph nodes after an 
initial relapse. Conclusions: These data suggest that adrenocorticotropin- 
secreting bronchopulmonary carcinoid tumors represent a distinct, more 
aggressive subtype of the usual, typical carcinoid. The high rate of 
lymphatic and local spread demands a surgical approach consisting of 
anatomic resection and routine mediastinal lymph node dissection. 
(J Thorac Cardiovasc Surg 1997;114:367-75) 
B ronchopulmonary carcinoids are low- to moder- ate-grade malignant neoplasms. As a result of 
their origin from neuroendocrine c lls, these tumors 
frequently secrete biologically active peptides. The 
most common of these is serotonin, implicated as 
the cause of the carcinoid syndrome, which occurs in 
up to 12% of patients with bronchial carcinoids. 1 
Less commonly, bronchial carcinoids elaborate hor- 
mones res;ulting in Cushing's yndrome, usually ad- 
renocorticotropin (ACTH). 2' 3 Although bronchial 
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carcinoids account for only 1% of cases of Cushing's 
syndrome, 4 most patients in whom this syndrome 
develops as a result of ectopic ACTH production 
have a source within the thorax. Among these 
intrathoracic sources, only bronchial carcinoids are 
likely to be cured. 5 This high therapeutic success 
rate, along with the remarkable clinical syndrome 
that these patients exhibit, lends unusual clinical 
interest o the association of bronchial carcinoids 
and Cushing's yndrome. 
Most documented cases of hypercortisolism asso- 
ciated with bronchial carcinoids have been reported 
individually. We present a series of seven consecu- 
tive patients with this disease process, which con- 
firms and extends the findings of previous small 
series. Our findings highlight he fact that although 
they are usually identified as typical carcinoids, 
bronchopulmonary carcinoids associated with Cush- 
ing's syndrome have a much more aggressive clinical 
behavior than other typical carcinoids and therefore 
require more aggressive surgical treatment than that 
which is accepted for other typical carcinoids. 
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Table I. Clinical and pathologic characteristics of  seven patients with Cushing's syndrome caused by 
bronchopulmonary carcinoid tumors 
Patient Time to 
(year) Age, sex Imaging studies Endocrine studies Dx Hypophysectomy 
1 22, M Sella tomos (-) ;  CT abd (-) ;  Urine cort 174; ACTH 102; 12 mo Yes, 2 
(1981) CXR (-) ;  CT chest (+); low-dose dex--no sup; 
pulm anglo ( - )  high-dose dex--sup 
2 20, F CT head (-) ;  CT abd (-) ;  Urine cort 549; ACTH 99; 12 mo Yes 
(1986) CXR (-) ;  CT chest (+) low-dose dex--no sup; 
high dose dex--sup; petr 
cath--central 
3 23, M MRI head equiv; CT abd Urine cort 1000; ACTH 31 mo Yes 
(1988) (-) ;  CXR (-) ;  CT/MRI 112; low-dose dex--no 
chest (+) sup; high dose dex--sup; 
petr cath--ectopic 
4 45, M CT/MRI head (-) ;  CT abd Urine cort 2189; ACTH 8 mo No 
(1992) (-) ;  CXR (-) ;  CT chest 191; low-dose dex--no 
(+); octr scan (+)* sup; high-dose dex-- 
sup 
5 74, F MRI head (-) ;  CXR (-) ;  Urine cort 500; ACTH 77; 6 mo No 
(1994) CT chest (+) low-dose dex--no sup; 
high dose dex--sup; petr 
cath--ectopic 
6 51, M MRI head (-) ;  CT abd (-) ;  Urine cort 929; ACTH 97; 84 mo No 
(1995) CXR (+); CT chest (+) low-dose dex--no sup; 
high-dose dex--no sup; 
petr cath--ectopic 
7 37, M MRI head (-) ;  CT abd (-) ;  Urine free cort 563; ACTH 18 mos No 
(1996) CXR (-) ;  octr scan (+)t; 100; low-dose dex--no 
CT chest (+)~ sup; high-dose dex§; petr 
cath--ectopic 
DX, Diagnosis; abd, abdomen; pulm angio, pulmonary angiography; urine cort, urinary free cortisol level; low~high-dose dex, low/high dose dexamethasone 
suppression test; sup, positive suppression f cortisol and ACTH levels;petr cath, inferior petrosal sinus ACTH sampling; equiv, equivocal result; (-), negative 
or normal study or lymph node; (+), positive study or lymph node involved with neoplastic process; LN, lymph node; octr, octreotide. 
*To diagnose r current disease insubcarinal node. 
tFor both initial disease and residual disease. 
:)High-resolution CT of chest was positive after standard cut CT of chest was negative for tumor. 
§Result not available. 
Patients and methods 
Between 1980 and 1996, seven patients were treated at 
the Massachusetts General Hospital for Cushing's syn- 
drome resulting from ectopic ACTH production by a 
bronchopulmonary carcinoid tumor (Table I). The medi- 
cal records and pathologic specimens of these patients 
were reviewed with attention to symptoms, diagnostic 
studies and time to diagnosis, surgical treatment, pathol- 
ogy, and outcome. The mean age of the patients was 34 
years. The group comprised five men and two women. 
Computed tomography (CT) of the chest was per- 
formed without contrast media by means of 10 mm cuts, 
except at the hila, where 5 mm cuts were used. Areas of 
interest were further delineated with 1.5 mm cuts. High- 
resolution scans used 5 mm cuts throughout the thorax. 
The low-dose dexamethasone suppression test involved 
measurement of cortisol evels after 0,5 mg orally every 6 
hours for 48 hours; the high-dose test used 2 mg orally 
every 6 hours for 48 hours. Octreotide scans were per- 
formed with multiple planar and single-photon emission 
computed tomography images of the head, neck, chest, 
and abdomen obtained 4 and 24 hours after intravenous 
administration of 200 mBg of indium i l l - l abe led  pento- 
treotide. Bilateral inferior petrosal sinus sampling was 
performed by placement of a 5F catheter into each internal 
jugular vein through a 5.5F introducer in a common femoral 
vein. After the administration of 5000 units of heparin, 
2.9F catheters were threaded into each inferior petrosal 
sinus and their positions confirmed by injection of contrast 
material. Venous samples for ACTH were drawn simul- 
taneously from each sinus and from the right common 
femoral vein at baseline and at 3, 5, 10, and 
15 minutes after intravenous injection of corticotropin- 
releasing hormone. Cushing's disease is suggested by a 
gradient from the central to peripheral ACTH levels, and 
the lack of a gradient suggests ectopic ACTH production. 
Operations were performed by means of a thoracotomy 
with perioperative intravenous steroid coverage, preoper- 
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Initial thoracic 
procedure Second thoracic procedure Pathology Outcome 
Bronchoseopy (-); Right lower lobectomy 12 days Atypical carcinoid; lymphatic Disease free 
wedge :resection postop for failure to nor- and aerogenous metastases; 
realize hormone levels and 3 hilar; 1 lobar LN (+); 
aggressive pathology second operation 
None Typical carcinoid; extensive 
lymphatic nvasion; no 








right lower lo- 
bectomy 
Bronchoscopy (-); 










Mediastinal LN dissection 29 mo 
postop after ecurrent hormone 
elevations and (+) octr scan 
None 
None 
Completion left upper lobec- 
tomy, mediastinal LN dissec- 
tion 4 weeks postop after 
failure to normalize and (+) 
octr scan 
Typical carcinoid; 1peribron- 
chial and 3 mediastinal 
LN (+) 
Typical carcinoid; lymphangitic 
spread; 3N1 LN's (+) and 
subcarinal LN (+) at second 
operation 
Typical carcinoid; all LN's (-) 
Typical carcinoid 
Frozen section at first opera- 
tion--typical carcinoid; per- 
manents--atypical; 1 N1 and 
1 N2 LN (+) at second op- 
eration 
Recurrent Cushing's 9
mo postop, no source 







ative antib:iotics, and single lung ventilation. Patients were 
slowly weaned from steroids after the operation after 
documentation that a fall to normal serum ACTH levels 
had been achieved. 
Results 
Symptoms. The patients with carcinoid-induced 
Cushing's yndrome demonstrated the typical clini- 
cal spectrum of severe hypercortisolism. Common 
signs and symptoms included muscle weakness or 
fatigue (all 7 patients), weight gain (6/7), striae (5/7), 
hypertension (5/7), acne (3/7), and "moon face" 
(3/7). Each of the patients had at least three of these 
symptoms. Only one of the patients had superim- 
posed syraptoms of the carcinoid syndrome--specif- 
ically, paroxysmal wheezing and flushing, without 
diarrhea. Signs or symptoms frequently associated 
with endobronchial tumors, such as cough, hemop- 
tysis, localized wheeze, or recurrent infections, were 
uniformly absent. 
Diagnosis. The mean time from the onset of 
symptoms to the discovery of a pulmonary lesion 
underlying the patients' Cushing's syndrome was 
24 months. During this period, the patients under- 
went a wide variety of diagnostic tests to determine 
the cause of their hypercortisolism. In all patients, 
the diagnosis of Cushing's yndrome was suspected 
on clinical grounds and confirmed by elevated 
levels of urinary free cortisol and serum cortisol, 
which failed to decrease with a low-dose dexameth- 
asone suppression test. The differential diagnosis 
for the cause of Cushing's syndrome was then 
narrowed in all patients to either pituitary hyper- 
secretion of ACTH (Cushing's disease) or ACTH 
secretion from a nonpituitary (ectopic) source by 
documentation of elevated serum ACTH levels. 
Mean serum ACTH in these patients was 109 
pg/ml (normal 6 to 76 pg/ml). 
In five of the six patients who underwent a 
high-dose dexamethasone suppression test, the 
cortisol levels suppressed, initially suggesting the 
erroneous diagnosis of Cushing's disease. This 
misleading result was followed in each case by CT 
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Fig. 1. Octreotide scan demonstrating activity in the sub- 
carinal region (arrow) in a patient with recurrent Cush- 
ing's syndrome 29 months after right lower lobectomy 
(patient 4). At reexploration a subcarinal node containing 
metastatic carcinoid was discovered. The areas of uptake 
inferiorly represent the liver and spleen. 
and/or magnetic resonance imaging (MRI) of the 
brain to examine the s lla turcica for the presence of 
a pituitary tumor. In one of these patients (patient 
3), brain MRI was believed to show some irregular- 
ity of the anterior pituitary, and transsphenoidal 
hypophysectomy was carried out directly. Pathologic 
examination revealed only pituitary hyperplasia, nd 
the patient's condition didnot improve. Ultimately, 
a chest CT scan was performed in this patient to 
demonstrate his bronchial carcinoid tumor, leading 
to appropriate treatment. 
In the other four patients with misleading sup- 
pression after high-dose dexamethasone, brain stud- 
ies did not demonstrate a pituitary lesion. This 
nondiagnostic result led to a search for an ectopic 
source of ACTH. Bilateral petrosal sinus catheter- 
ization for measurement of serum ACTH levels was 
performed in two of these patients and demon- 
strated a higher central than peripheral ACTH level 
in one (patient 2). On that basis, this patient under- 
went a transsphenoidal hypophysectomy, also with- 
out improvement. Adrenal tumors, although un- 
likely in the setting of elevated serum ACTH levels, 
were nevertheless ruled out in three of these four 
patients by abdominal CT. Ultimately, chest CT 
demonstrated a nodule and led to the correct diag- 
nosis in each of these four patients. 
The single patient in whom cortisol evels failed to 
suppress on high-dose dexamethasone testing (pa- 
tient 6) also underwent brain MRI, which confirmed 
the absence of a pituitary lesion, and abdominal CT, 
which excluded adrenal masses. The results of 
petrosal sinus catheterization also supported the 
diagnosis of a nonpituitary ACTH source in this 
patient. A nodule was then identified on a chest CT, 
leading to appropriate treatment by nodule excision. 
The final patient (patient 7) did not undergo a 
high-dose dexamethasone test but also underwent 
petrosal sinus catheterization, which suggested a
nonpituitary ACTH source. Again, brain MRI re- 
vealed a normal sella turcica and abdominal CT 
revealed no adrenal masses. In this patient, both a 
chest roentgenogram and an initial chest CT scan 
revealed no lesions. An octreotide scan was per- 
formed because of the high suspicion of a carcinoid 
tumor given the experience with the other patients 
in this series, all of whom were seen before this 
patient. This study revealed an area of uptake in the 
left upper lobe. The presence of this lung nodule 
was then confirmed by chest CT repeated with finer 
cuts. The two other times an octreotide scan was 
performed were in the same patient when the 
hormone levels failed to normalize after initial 
resection, and in a patient in whom recurrent Cush- 
ing's syndrome developed 29 months after the initial 
resection (see below). In each of these patients, the 
scan localized recurrent disease that was surgically 
resected, in the ipsilateral subaortic region and in 
the subcarinal area (Fig. 1), respectively. 
The initial chest roentgenogram showed no lesion 
in six of the seven patients. The lesions on chest CT 
and MRI were in the right middle lobe in three 
patients, the right lower lobe in two patients, and the 
left upper lobe in two patients. They ranged in size 
from 7 mm to 2.5 cm in maximal diameter with a 
mean of 1.5 cm. Enlarged mediastinal lymph nodes 
were identified on chest CT in one patient. All of the 
patients underwent bronchoscopy, which identified 
no endobronchial lesions. Other than bronchoscopy, 
the only preoperative procedure performed in an 
attempt o establish a tissue diagnosis was a single 
attempted transthoracic needle biopsy, which recov- 
ered normal ung tissue. 
Surgical procedures and outcome. All seven pa- 
tients eventually underwent surgical resection of a 
bronchial carcinoid tumor. In all patients, ACTH 
levels fell to normal range within 1 week of the final 
intrathoracic operation. Four of the seven, however, 
required a second procedure for persistent or recur- 
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Fig:. 2. A, Photomicrograph (hematoxylin and eosin stain, original magnification × 10) of section of the 
primary tumor from patient 4,demonstrating the classic features of a typical carcinoid. B, Photomicrograph 
(original magnification ×2.5) of involved lymph node from the same patient. Areas of tumor invasion and 
surrounding normal lymph node are visible. 
rent hypercortisolism before achieving a lasting 
cure. In one of these patients (patient 2), the second 
procedure was bilateral adrenalectomy. The six pa- 
tients who were ultimately rendered free of symp- 
toms and biochemically cured by intrathoracic pro- 
cedures remain so a mean of 59 months after the 
operation (range 5 to 180 months). No perioperative 
complications developed. 
The primary pulmonary resections performed in- 
cluded formal lobectomy in three patients, anatomic 
segmentectomy in one, wedge resection in two, and 
precision cautery excision in one. In all patients, the 
interlobar regions and mediastinum were palpated for 
enlarged lymph nodes, and these were resected when 
present (four patients). In one patient, this policy 
identified involved inferior pulmonary ligament nodes 
on frozen section examination and resulted in conver- 
sion of a wedge resection to a lobectomy. 
In this small group of patients, no clear correla- 
tion existed between extent of initial resection and 
outcome. Three of the six patients who were ulti- 
mately cured by intrathoracic procedures required a
second chest exploration for recurrent or persistent 
Cushing's syndrome. Two of these three patients 
had undergone an anatomic resection. The second- 
ary procedures included mediastinal lymphadenec- 
tomy 29 months after lobectomy in one patient (Fig. 
1) and completion lobectomy with mediastinal 
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lymphadenectomy 12 days and 1 month after wedge 
resection and segmentectomy, respectively. Each of 
these patients remain free of symptoms 20, 180, and 
9 months after the second procedure. In contrast to 
these patients, two of whom underwent anatomic 
resections only to have a relapse, the patient who 
underwent he least extensive initial resection-- 
precision cautery excision--required no further 
treatment and remains apparently free of disease 18 
months after the initial procedure. The other two 
patients, who underwent primary lobectomy, are 
well 29 and 96 months after the operation. 
Three patients underwent ranssphenoidal hy- 
pophysectomy before pulmonary resection. One of 
these patients underwent two transsphenoidal pro- 
cedures. Each of these patients, including the one 
(patient 2) who was found to have a gradient 
between central and peripheral ACTH levels on 
petrosal sinus catheterization, was found histologi- 
cally to have pituitary hyperplasia without adenoma. 
The findings of hyperplasia nd high central ACTH 
secretion were explained on examination of the 
carcinoid tumor that was ultimately resected from 
the right middle lobe of patient 2. Immunostaining 
revealed this lesion to secrete both ACTH and 
corticotropin-releasing hormone. This phenomenon 
has been previously described in the literature. 6 This 
patient ultimately required bilateral adrenalectomy 
for recurrent Cushing's syndrome with no clear 
source 14 months after pulmonary resection, and 
the other two who underwent transsphenoidal hy- 
pophysectomy were cured by pulmonary resection. 
Pathology and outcome. Five of the seven re- 
sected tumors were considered to be typical carci- 
noids by the standard histologic riteria established 
by Arrigoni, Woolner, and Bernatz 7 (Fig. 2). How- 
ever, four tumors, including both atypical tumors, 
demonstrated either extensive lymphatic or exten- 
sive vascular invasion. In the five cases in which 
lymph nodes were present in the surgical specimen, 
they were positive for metastatic carcinoid in four. 
The three tumors that were immunostained were 
positive for ACTH. 
In contrast o the lack of a relationship between 
extent of resection and outcome, there did appear to 
be a correlation between the intrinsic aggressiveness 
of the tumors and outcome in these patients. All 
four patients with extensive lymphatic or vascular 
invasion required a second procedure to be cured of 
Cushing's syndrome. Two of these patients had 
involved lymph nodes at the time of initial opera- 
tion. All three patients who had both typical carci- 
noid and no evidence of aggressive local invasive 
characteristics were cured by the initial resection. 
The failure of the initial resection to cure four 
patients appears in at least hree to have been due to 
unresected metastatic disease in lymph nodes. In the 
patient (patient 4) who underwent mediastinal 
lymphadenectomy after lobectomy, a single subcari- 
nal node was found to contain metastatic carcinoid 
tumor (Fig. 2). In the patient (patient 7) who 
underwent completion lobectomy and mediastinal 
lymphadenectomy after segmentectomy, two of five 
lymph nodes were found to contain metastatic car- 
cinoid, including a subaortic lymph node. Finally, in 
the patient (patient 1) who underwent completion 
lobectomy and mediastinal lymphadenectomy after 
wedge resection, three of five hilar lymph nodes and 
one lobar node were found to contain metastatic 
carcinoid. In total, at least three of seven patients 
(43%) had N2 disease and four of seven (57%) had 
diseased lymph nodes at some level. 
Discussion 
Although it contains only seven cases, this series is 
among the largest reported of ACTH-secreting 
bronchopulmonary carcinoid tumors resulting in 
Cushing's yndrome. 2' 3 The preponderance of pub- 
lished information on this association is in the form 
of individual case reports. 2 Taken together, this and 
previous eries suggest that these tumors are mark- 
edly more aggressive than hormonally quiescent 
typical carcinoids. As a result, these tumors require 
more aggressive surgical control than other typical 
carcinoids. Further, our experience with this uncom- 
mon disease process allows us to suggest a diagnos- 
tic algorithm that could avert much of the significant 
patient suffering and diagnostic expense related to 
the lesion. 
As in previous series, all of our patients had 
symptoms of glucocorticoid excess without signs or 
symptoms referable to the local effects of the pul- 
monary tumor. In 86% of our patients the chest 
roentgenogram showed no abnormalities, imilar to 
the figure (67% of patients) in each of the two prior 
series of carcinoids causing Cushing's syndrome. 
None of our patients had a tumor identified within 
the airways at bronchoscopy, similar to the figures 
(100% and 75% of patients with normal broncho- 
scopic results) in the two prior series. These results 
are in stark contrast o patients with hormonally 
inactive bronchial carcinoids, more than half of 
whom have cough, hemoptysis, or dyspnea; more 
than 75% of whom have an abnormalities on the 
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Petrosal sinus catheterization 
no ~ s r ~ t  
likely Dx: ectopic ACTH source 
I 
chest CT with 5 mm cuts 
anatomic pulmonary resection octreotide 
with mediastinal lymph node scan 
dissection 
likely Dx: Cushing's Disease 
head CT or MRI 
transsphenoidal 
hypophysectomy 
chest CT with 5 mm cuts 
+/- abdominal CT 
Fig. 3. Recommended diagnostic algorithm for patients with Cushing's yndrome and elevated serum 
ACTH. Dx, Diagnosis; ACTH, adrenocorticotropin; CT, computed tomography; MR/, magnetic resonance 
imaging. 
chest roentgenogram; and in whom tumors are 
frequently visible on bronchoscopic examination. 1' 8, 9 
The ACTIt-secreting carcinoids, then, would appear 
to fall within the subcategory of carcinoids identified 
by Wilkins and associates 1° as "peripheral pulmonary 
carcinoids." 
With pulmonary tumors as small as those in this 
series, chest CT is the most reliable diagnostic 
modality. When 5 mm cuts were used, this test 
identified the tumor in each of our patients. The 
ideal work-up of these patients, then, would include 
early, high-resolution chest CT. As in previous se- 
ries, however, there was a significant delay in reach- 
ing an accurate diagnosis in our patients. The aver- 
age time to diagnosis was 24 months. A large factor 
in this delay is unavoidable--the normal chest 
roentgenographic f ndings and absence of pulmo- 
nary symptoms. Another factor, however, was the 
fact that raost of these tumors (83%) misleadingly 
were suppressed on high-dose dexamethasone sup- 
pression testing. This was documented in one of the 
prior series, 3but not with the frequency seen in this 
series. It has been noted by others that metyrapone 
stimulation 11and ovine corticotropin-releasing hor- 
mone stimulation 12are similarly nonspecific in iden- 
tifying the source of ACTH as ectopic when that 
source is a carcinoid. The classic tests used to 
differentiate central from ectopic hypercortisolism, 
then, appear to be relatively unhelpful in this group 
of patients. This inevitably leads to the performance 
of other studies, such as brain and abdominal CT or 
MRI and inferior petrosal sinus catheterization, 13 
when a chest CT might otherwise be performed first. 
Given the unreliability of high-dose dexametha- 
sone suppression and other biochemical tests, and 
the fact that the thorax is the most common site of 
ectopic ACTH secretion if one includes small-cell 
carcinoma of the lung, 14 we propose a more efficient 
approach to diagnosis in patients with Cushing's 
syndrome and elevated ACTH (Fig. 3). This ap- 
proach would begin with inferior petrosal sinus 
catheterization and proceed directly to chest CT 
when catheterization suggests an ectopic source. 
Such an approach would be likely to decrease both 
the time to diagnosis and the cost of coming to a 
diagnosis, because brain CT or MRI and abdominal 
CT would be rendered unnecessary, and the confu- 
sion surrounding the suppression and stimulation 
testing results would be averted. As demonstrated 
by our patient with an ectopic source of both ACTH 
and corticotropin-releasing hormone, petrosal sinus 
catheterization can occasionally be misleading, but 
this would appear to be an exceedingly rare event. 
Although submitting the vast majority of patients 
who have a central source for their Cushing's yn- 
drome to petrosal sinus catheterization may strike 
some as unduly invasive, adoption of such a schema 
is the only way to assuredly prevent he minority 
with an ectopic source from undergoing unnecessary 
transsphenoidal hypophysectomy. Finally, octreotide 
scanning (see Fig. 1) may be useful in the event hat 
all evidence points to an ectopic source but chest CT 
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is unrevealing. 15In each instance in which we used 
this imaging modality in patients with recurrent or 
residual disease, it correctly directed us to the site of 
disease. 
This series of cases emphasizes that many of these 
tumors are relatively aggressive and therefore re- 
quire complete mediastinal lymph node dissection 
for cure. Three of our seven patients (43%) had 
involved, resectable mediastinal lymph nodes, simi- 
lar to the finding of 35% to 54% abnormal lymph 
nodes in prior studies. 2'~ Although the majority of 
carcinoids in this and previous series of carcinoid- 
associated Cushing's syndrome are "typical" carci- 
noids, this rate of lymphatic metastasis remark- 
ably higher than the 4% to 11% rate seen for all 
typical carcinoids, ' 10, 16 These metastatic rates are 
higher, in fact, than that reported in a recent, 
representative s ries of atypical carcinoids in which 
only 22% of patients had N2 disease at the time of 
surgical treatment.17 In a previously published series 
of 111 patients from our institution, consisting of 
typical and atypical bronchopulmonary carcinoids, 
although five of the 11 patients with atypical tumors 
died of metastatic disease an average of 33 months 
after the operation, the only patient who required a 
second thoracotomy for locally recurrent disease 
was the single patient with an ACTH-secreting 
tumor (included in the current series). In that series, 
lymph node metastases were found with 5% of 
typical and 36% of atypical tumors, and no patient 
died of spread of a typical carcinoid. 1° 
This information, coupled with our finding that 
57% of the tumor specimens demonstrate ither 
lymphatic or vascular invasion, suggests that carci- 
holds which secrete ACTH, although they may not 
meet standard criteria for "atypicality" and appear 
to have a lower mortality rate than nonsecreting, 
atypical carcinoids, nevertheless demonstrate more 
malignant characteristics than nonsecreting, typical 
carcinoids. These tumors appear to lie somewhere 
on the spectrum of malignancy between hormonally 
quiescent typical and atypical carcinoids. It would 
seem appropriate to label them Kulchitsky cell 
carcinoma type lib by the classification scheme of 
Paladugu and associates, I  bearing metastatic po- 
tential similar to atypical carcinoids or well-differ- 
entiated neuroendocrine carcinomas according to 
the classification system proposed by Warren, 
Faber, and Gould, 19 but without he same ramifica- 
tions for survival. 
Clearly, adequate surgical treatment for tumors 
that demonstrate such high rates of mediastinal 
lymph node metastasis must include mediastinal 
lymph node dissection. Control of these tumors will 
be accomplished with the most regularity by adher- 
ing to an approach of anatomic resection with 
routine, complete mediastinal lymph node dissec- 
tion. The use of video-assisted techniques in these 
patients would be inappropriate. 
In summary, bronchopulmonary carcinoid tu- 
mors that secrete ACTH are a distinct clinical and 
pathologic entity. These tumors are generally 
peripheral in location and cause symptoms result- 
ing from hypercortisolism rather than from local 
tumor effects. Their discovery may be difficult but 
can be made simpler by adhering to the diagnostic 
plan outlined herein. Although they are usually 
typical carcinoids by standard histologic criteria, 
they have a much greater metastatic potential 
than hormonally quiescent typical carcinoids and 
would appear to more closely resemble atypical 
carcinoids in this regard. Surgical treatment of 
these tumors, therefore, should be approached in 
the same manner as has been proposed for more 
aggressive malignant umors and should include 
anatomic resection and routine, thorough medi- 
astinal lymph node dissection. This approach will 
result in high rates of cure. 
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